---
indicator_name: global_indicators.3-d-2-title
target_name: global_targets.3-d-title
indicator_number: 3.d.2
csv_size: 4.635 kB
national_indicator_description: Data are presented for bloodstream infections S. aureas (MRSA)and E.coli. Please use the units type button to navigate between infection type.
un_custodian_agency: World Health Organisation (WHO)
goal_meta_link: https://unstats.un.org/sdgs/metadata/files/Metadata-03-0D-02.pdf
national_geographical_coverage: England, Wales and Northern Ireland
computation_units: Rate per 100000, Percentage (%)
computation_definitions: >-
  Cephalosporins are a type of antibiotic used to treat bacterial infections. The 3rd generation cephalosporins considered in this indicator are - cefotaxime, ceftazidime, cefpodoxime and/or ceftriaxone. Tests to one or multiple are taken into account, and the most resistant test result
  retained.
reporting_status: complete
data_non_statistical: false
graph_type: line
graph_titles:
  - unit: MRSA bloodstream infection
    title: Rate of MRSA bloodstream infection reports per 100,000 population
  - unit: Proportion (%) of 3rd generation cephalosporin resistant E. coli blood specimens
    title: Rolling quarterly average proportion of 3rd generation cephalosporin resistant E. coli blood specimens in England
data_show_map: false
data_keywords: Antimicrobial resistance, E.coli, MRSA
source_active_1: true
source_organisation_1: Public Health England
source_periodicity_1: Quarterly
source_earliest_available_1: 2016 Q4
source_geographical_coverage_1: England
source_url_1: https://fingertips.phe.org.uk/profile/amr-local-indicators
source_url_text_1: AMR Local Indicators
source_release_date_1: 02/02/2021
source_next_release_1: TBA
source_statistical_classification_1: Official
source_contact_1: profilefeedback@phe.gov.uk
source_other_info_1: >-
  To navigate to data select "start." For data view select "Trends," for geography select "Acute Trusts" and for topic select "Antimicrobial Resistance." Under indicator select "Rolling quarterly average proportion of 3rd generation cephalosporin resistant E. coli blood specimens; by
  quarter."
source_active_2: true
source_organisation_2: Public Health England
source_periodicity_2: Annual
source_earliest_available_2: 2014
source_geographical_coverage_2: England, Wales and Northern Ireland
source_url_2: https://www.gov.uk/government/publications/staphylococcus-aureus-annual-trends-in-voluntary-surveillance
source_url_text_2: Staphylococcus aureus - annual trends in voluntary surveillance
source_release_date_2: 16/08/2019
source_next_release_2: TBA
source_statistical_classification_2: Official
source_contact_2: hcai.amrdepartment@phe.gov.uk
source_other_info_2: See Table 1a of linked source
source_active_3: false
source_active_4: false
source_active_5: false
source_active_6: false
other_info: >-
  <p>For E.coli blood specimens, a higher value is indicative of increased 3rd generation cephalosporin resistance. Data are only available for the NHS and private laboratories signed up to report to Public Health Englandâ€™s voluntary surveillance system SGSS antimicrobial testing
  module.</p> Data follows the UN specification for this indicator. This indicator has been identified in collaboration with topic experts.
---
